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Metal complexGalectin-3, a ubiquitous member of the galectin family, has been shown to control cellular proliferation,
adhesion, migration and apoptosis; thus, it has a role in tumor development and progression. Galectin-3
expression is both up- and down-regulated during melanoma progression. However, conﬂicting data
regarding its roles in tumor biology prompted us to investigate if the presence of galectin-3 inﬂuences
the response of melanoma cells to a novel metallodrug because metastatic melanoma acquires chemo
resistance and is reported to be redox-sensitive. Previously, it was demonstrated that the complex
[bis-(2-oxindol-3-yl-imino)-2-(2-aminoethyl) pyridine-N,N0] copper (II) perchlorate, herein referred to
as [Cu(isaepy)], induces ROS formation and apoptosis in neuroblastoma cells through mitochondrial
uncoupling and the activation of AMPK/p38/p53 signaling. Here, we used a model of vertical growth mel-
anoma (TM1), in which GAL3 expression is lost during tumor progression. When de novo expressed, galec-
tin-3 was found to be ubiquitously present in all subcellular compartments. Our results demonstrate that
de novo galectin-3 expression impairs the cellular antioxidant system and renders TM1G3 cells more sus-
ceptible than GAL3-null TM1MNG3 cells to [Cu(isaepy)] treatment. This compound, in contrast with the
redox inactive [dichloro (2-oxindol-3-yl-imino)-2-(2-aminoethyl) pyridine-N,N0] zinc (II), herein referred
to as [Zn(isaepy)], leads to increased intracellular ROS accumulation, increased carbonyl stress, increased
mitochondrial depolarization, decreased cell adhesion, increased p38 activation and apoptosis in TM1G3,
compared with TM1MNG3. Cell death was shown to be dependent on a hydrogen peroxide-derived spe-
cies and on the activation of p38. Because mitochondria are a target of both [Cu(isaepy)] and galectin-3,
we propose that the presence of galectin-3 in this organelle favors increased ROS production, thereby
inducing oxidative cellular damage and apoptotic death. Therefore, [Cu(isaepy)] may be envisaged as a
possible anti-melanoma strategy, particularly for melanomas that express galectin-3.
 2013 Elsevier Ireland Ltd. All rights reserved.1. IntroductionGalectin-3 is a ubiquitous member of the galectin family. This
lectin is found intracellularly, in the plasma membrane and in
the extracellular space [1,2]. Galectin-3 is involved in several pro-
cesses, such as cell proliferation, adhesion, migration and apopto-
sis, and is essential for cellular physiology, inﬂammation, tissue
repair and tumor biology. Clinical studies using human tissues
have shown that galectin-3 expression is both up-regulated [2–7]
and down-[8–11] regulated during tumor progression, including
during melanoma development [11–14].
Malignant melanoma is the most aggressive form of skin cancer
and accounts for 80% of all skin cancer deaths [15]. Currently ap-
proved therapeutic drugs consist of dacarbazine and interleukin-
2, which are associated with a poor response. Although some novel
targeted therapies are emerging [16,17], including immunotherapy
38 B.E. Borges et al. / Chemico-Biological Interactions 206 (2013) 37–46and combined drugs, their long term consequences are still un-
known [18]. Therefore, novel therapies are clearly required.
Metallodrugs have long been used as antitumor drugs [19]. This
class of compounds is particularly interesting as a potential source
of novel antimelanoma drugs because melanoma is considered to
be very redox-active and sensitive to reactive oxygen species
(ROS) [20–22]. The complex produced by copper (II) and disulﬁ-
ram, for instance, induces apoptosis in melanoma cells [23]. Re-
cently, some metal ligands have been designed [24] based on
similarities with indole derivatives (SU9516 or SU6668), which
have already been described as inhibitors of the cyclin-dependent
kinases [25]. Copper (II) ions, when coordinated with isatin or isat-
in-derived ligands, induce ROS production, which results in the
oxidation of key biomolecules [24,26]. Indeed, the [Cu(isaepy)]
complex exhibits anti-neuroblastoma activity by inducing ROS for-
mation, mitochondrial toxicity and apoptosis [24,27–29].
Here, we used a melanoma cell line that lost galectin-3 expres-
sion during in vitro tumor progression [30,31] and investigated the
effect of de novo galectin-3 expression following challenge with the
[Cu(isaepy)] complex. Our data show that intracellular galectin-3
expression impairs the melanoma antioxidant system and renders
cells more susceptible to apoptosis when treated with this copper
complex. The mechanisms of cytotoxicity include ROS formation,
carbonyl stress, mitochondrial depolarization, p38 activation and
cell adhesion inhibition. These processes were most evident in
the galectin-3-expressing cells. These results indicate that galec-
tin-3 increases the susceptibility of melanoma cells to apoptosis,
and this is most likely to occur through the inﬂuence of the protein
on the redox effects triggered by [Cu(isaepy)] because the analo-
gous redox inactive [Zn(isaepy)] produced no detectable effect.2. Material and methods
2.1. Cell lines
Melanoma TM1MNG3 and TM1G3 cells were obtained by stably
transfecting TM1 cells [30] with either the pEF1-neo or the pEF1-
neo-Gal3 plasmid (kindly donated by Fu-Tong Liu, University of
California, Davis), respectively. The cells were routinely cultured
in RMPI medium (pH 6.9) (Cultilab, Campinas, Brazil) containing
40 lg/mL gentamicin and 5% fetal calf serum.2.2. Metal compounds and cell treatment
The copper complex [bis-(2-oxindol-3-yl-imino)-2-(2-amino-
ethyl) pyridine-N,N’] copper (II) perchlorate, [Cu(isaepy)2](ClO4)2,
referred to as [Cu(isaepy)], and the analogous zinc complex [di-
chloro (2-oxindol-3-yl-imino)-2-(2-aminoethyl) pyridine-N,N’]
zinc (II), [Zn(isaepy)Cl2], referred to as [Zn(isaepy)], were synthe-
sized as described [24]. Stock solutions of these complexes
(5 mM) were prepared in 10% DMSO and were stored at 20 C.
These solutions were diluted to their ﬁnal concentrations immedi-
ately before the experiments. An aqueous DMSO solution, corre-
sponding to the highest DMSO concentration (0.1%) in the metal
solutions, was employed as a vehicle control. Typically, the cells
were plated and then treated with the metal complexes for 24 h
(or for the speciﬁed time) after they had adhered to the plate (usu-
ally 4 h later).2.3. Cell extracts and cell fractionation
Protein extracts and protein cell fractions were prepared as pre-
viously described [32].2.4. SDS–PAGE and immunoblotting
Protein separation and immunoblotting were performed as pre-
viously described [33]. The antibodies used were rat monoclonal
anti-galectin-3 M3/38 (TIB166, ATCC, 1:10), rabbit anti-p38 and
anti-phospho-p38 (Cell Signaling, Boston, USA, 1:1000), anti-rat
IgG coupled to HRP (Sigma–Aldrich, São Paulo, Brazil) (1:1000),
anti-lamin A (Santa Cruz Biotechnology, Dallas, TX, USA)
(1:1000), anti-cytochrome c (Santa Cruz Biotechnology) (1:200),
anti-GAPDH (Sigma–Aldrich, São Paulo, Brazil) (1:1000), home-
made polyclonal anti-PrPc (1:1000), anti-mouse IgG coupled to
HRP (Sigma–Aldrich, São Paulo, Brazil) (1:10,000) and anti-rabbit
IgG coupled to HRP (Sigma–Aldrich, São Paulo, Brazil) (1:10,000).
The reactions were developed with the West Pico ECL system
(Pierce, Rockford, USA).
2.5. Proliferation assay
Cells were plated at a density of 5  104 cells/well in 96-wells
microplates. Twenty-four hours later, the cells were ﬁxed with
3% paraformaldehyde for 10 min and then incubated with 100 lL
of 2% methanol for 10 min before being stained for 10 min with
30 lL of 0.5% crystal violet (Sigma–Aldrich, São Paulo, Brazil) dis-
solved in 20% methanol (Synth, Diadema, Brazil). The cells were
then washed with water, and the dye was extracted with 100 lL
of 0.1 M sodium citrate (pH 4.2) containing 50% methanol. The
absorbance was read at 570 nm in a microplate reader (BioRad,
Hercules, CA, USA).
2.6. Melanin determination
Melanin content was measured as previously described [33].
Brieﬂy, 24 h after the cells were plated, 5  105 cells were collected
and lysed in 1 M NaOH/10% DMSO. The samples were then boiled
for 1 h. The absorbance of the supernatant was determined at
490 nm. The B16F10 and SHSY-5Y cell lines were used as positive
and negative controls, respectively.
2.7. Cell adhesion
Ninety-six-wells plates were coated with 15 lg/mL laminin,
matrigel (puriﬁed according to [34]), vitronectin (puriﬁed accord-
ing to [35]) or ﬁbronectin (puriﬁed according to [36]) and incu-
bated for 16 h at 4 C. The wells were washed and blocked with
2% BSA for 2 h. The cells were treated for 24 h and were then
seeded (104 cells/well) and incubated for 2 h. Adhered cells were
ﬁxed with 3% paraformaldehyde and stained with 0.4% methylene
blue in 30% methanol. The dye was extracted with 0.5% acetic acid
in 50% methanol. The absorbance was read at 655 nm in a micro-
plate reader (BioRad, Hercules, CA, USA).
2.8. Cell viability
Cells were plated at a density of 5  104 cells/well in a 96-wells
microplate. Twenty-four hours after treatment with the metal
complexes, or with 20 lM menadione (Sigma–Aldrich, São Paulo,
Brazil), the cells were washed and incubated with 200 lL of
0.5 mg/mL MTT solution (Sigma–Aldrich, São Paulo, Brazil) for
3 h in a CO2 incubator. The cells were then washed, and formazan
crystals were extracted with 200 lL of DMSO (Sigma–Aldrich, São
Paulo, Brazil). The absorbance was read at 570 nm in a microplate
reader (BioRad, Hercules, CA, USA). In some assays, the cells were
incubated with 25 U/mL Peg-SOD (Sigma–Aldrich, São Paulo, Bra-
zil) and/or 200 U/mL Peg-CAT (Sigma–Aldrich, São Paulo, Brazil)
in addition to the metal compounds.
B.E. Borges et al. / Chemico-Biological Interactions 206 (2013) 37–46 392.9. Apoptosis analysis
Cell death was analyzed by cytoﬂuorometry (BD, Franklin Lakes,
NJ, USA) using a commercial kit (Sigma–Aldrich, São Paulo, Brazil)
that stains cells with annexin-V-FITC and propidium iodide, and
the staining was performed in accordance with the manufacturer’s
recommendations. Thirty thousand events were counted.
2.10. Protein carbonyl determination
Fifty micrograms of cellular protein extract, prepared as de-
scribed above, were used. Carbonyl levels were determined as pre-
viously described [37]. Absorbance was measured at 360 nm in a
microplate reader.
2.11. Glutathione-S-transferase (GST), superoxide dismutase (SOD)
and hydrogen peroxide decomposition activities
Global GST activity was measured using reduced GSH and 1-
chloro-2,4-dinitrobenzene (CDNB) as substrates [38]. After treat-
ment, cells were scraped, and 2  106 cells were collected, washed
and lysed in 0.2–0.5 mL of lysis buffer (0.1 M phosphate buffer, pH
7.0), 1 mM EDTA, 0.1% NP40). After centrifugation at 9000g for
20 min at 4 C, the supernatant (S9) was placed in a 96-wells
microplate. Reaction medium (1.5 mM glutathione (GSH), 2.0 mM
CDNB, 0.1 M phosphate buffer, pH 7.0) was immediately added
to the supernatant, and the absorbance increase was immediately
measured at 340 nm for 4 min in intervals of 15 s. Reaction med-
ium and PBS were used as blanks. GST activity was determined
using the molar extinction coefﬁcient for CDNB, 9.6 mM1 cm1.
Superoxide dismutase (SOD) activity was determined as described
[39]. Brieﬂy, protein extracts were prepared in 20 mM Tris–HCl, pH
7.6, containing 2.0 mM EDTA and 1 mM PMSF. SOD activity of
30 lg of soluble protein was assessed by its ability to inhibit the
reduction of 100 lM nitroblue tetrazolium. The reduction was fol-
lowed photometrically at 560 nm. Hydrogen peroxide decomposi-
tion was determined as described [40].
2.12. GSH determination
The concentration of non-protein sulfhydryl groups (mainly
GSH) was determined using a method adapted from [41]. Brieﬂy,
1  106 cells were treated with the metal compounds for 16 and
24 h and then collected. One aliquot was set aside to determine
the protein concentration. A second aliquot was incubated with
10% trichloroacetic acid (TCA). The acid supernatant (50 lL) was
neutralized with 1 M Tris buffer (pH 9.0) and incubated with
0.5 mM DTNB (Sigma–Aldrich, São Paulo, Brazil). Authentic GSH
(Sigma–Aldrich, São Paulo, Brazil) was used to construct a standard
curve. The absorbance was read at 412 nm in a microplate reader.
The data are expressed as nmoles/mg protein.
2.13. Intracellular ROS detection
Cells (1  106 cells) were treated for 24 h, and then detached
and incubated for 5 min with 10 lM 20,70-dichlorodihydroﬂuores-
cein diacetate (DCFH2-DA) [42]. Fluorescence readings from
30,000 cells were acquired using a FACSCalibur cytometer (BD,
Franklin Lakes, NJ, USA), and the data were analyzed using the
Win MDI 2.8 software program.
2.14. Mitochondrial function
Mitochondria inner membrane depolarization was determined
with the probe JC-1™ (Molecular Probes, OR, USA), according to
the supplier’s recommendations, in a FACSCalibur cytometer (BD,Franklin Lakes, NJ, USA), and the data were analyzed using the
Win MDI 2.8 software program. Staurosporine (1 lM, 24 h, Sig-
ma–Aldrich, São Paulo, Brazil) was used as a positive control. The
intracellular ATP levels were determined as described [43]. Brieﬂy,
cells were treated with the metal complexes as described above.
After 24 h, 2  106 viable cells were collected and submitted to
HPLC analysis [43]. Our HPLC instrument consisted of a Shimadzu
Prominence system (Tokyo, Japan) equipped with a Rheodyne
injector (model 7125), a quaternary pump (LC-20AD), controlled
by the LC Solution software, and a UV–VIS detector (SPD-7AV),
set at 260 nm. Separation was achieved with a 150  4.6 mm C18
Gemini column (Phenomenex, Torrance, CA USA), eluted with
1 mL/min of 100% buffer A from 0 to 5 min, followed by a gradient
of 100% buffer A to 100% buffer B, from 5–20 min, returning to
100% buffer A from 20 to 25 min. Buffer A consisted of a 25 mM
phosphate buffer pH 5.0 containing 100 mg/L tetrabutylammo-
nium hydrogen sulfate (Sigma–Aldrich, São Paulo, Brazil) and buf-
fer B consisted of 200 mM phosphate buffer pH 5.0 containing
100 mg/L tetrabutylammonium hydrogen sulfate and 10% acetoni-
trile (Carlo Erba, Val de Reuil, France). Quantitation of ATP was per-
formed by integration of the corresponding HPLC peaks and
comparison of the areas obtained with those obtained for the stan-
dards under the same HPLC conditions.
2.15. p38 activation
The phosphorylation of p38 was monitored by immunoblotting
as described above. The cells were incubated with the metal com-
pounds in the presence or absence of a 10 lM concentration of a
p38 inhibitor, either SB203580 or SB239063, or of an inactive
p38 inhibitor SB202474 (Calbiochem-Merck, Darmstadt, Ger-
many), for 24 h. Cell viability was determined using the MTT assay
as described above.
2.16. Statistical analysis
The data are presented as the mean ± S.D. from at least 3 inde-
pendent experiments. A one-way ANOVA test, followed by Tukey’s
test, was used for the dose-dependent cytotoxicity assay. For the
other experiments, statistical analysis was performed using a sin-
gle-mean Student’s t test. Graphs were generated using the Graph-
Pad Prism software program. In all analyses, p < 0.05 was
considered statistically signiﬁcant.3. Results
3.1. Characterization of the melanoma cell lines
The cell lines used in this work were generated by tumor pro-
gression from melan-a melanocyte cell line [30]. These cells were
stably transfected with a galectin-3-expressing vector (TM1G3
cells) or the corresponding empty vector (TM1MNG3 control cells).
Immunoblotting analysis of galectin-3 expression in cellular ex-
tracts (Fig. S1A) and subcellular fractions conﬁrmed that galec-
tin-3 was expressed in all fractions of the TM1G3 cells (Fig. 1A).
Additionally, the indirect immunoﬂuorescence assay demon-
strated that galectin-3 is ubiquitously present within the cell
(Fig. S1B). Phenotypically, these two cell lines have some differ-
ences. The galectin-3 null TM1MNG3 cells have no detectable mel-
anin, similar to neuroblastoma SHSY-5Y cells, while the TM1G3
cells have a higher pigment level that is, nevertheless, lower than
that of the heavily melanogenic B16F10 cells (Fig. 1B). Recently, a
possible association between galectin-3 expression and melano-
genesis has been suggested by the results of a study using primary
melanoma tissues; while acral lesions did not express galectin-3,
Fig. 1. Characterization of TM1MNG3 and TM1G3 cells. (A) Subcellular protein fractions (50 lg/lane) were resolved on a 15% SDS–PAGE gel and transferred to a
nitrocellulose membrane, which was then incubated with a rat anti-human galectin-3 antibody, anti-lamin A, anti-cytochrome c, anti-PrPc (cellular prion protein) and anti-
GAPDH, followed by the respective secondary antibodies coupled to HRP. A chemiluminescent reaction was performed using the West Pico ECL kit. The image shown here is
representative of 2 assays. (B) Melanin content was determined by photometry. Brieﬂy, cells were plated and 24 h later, 5  105 cells were collected, lysed in 1 M NaOH, and
boiled for 1 h. The absorbance of the supernatant was read at 490 nm. SHSY-5Y and B16F10 cell lines were used as positive and negative controls, respectively. (C) Cell
proliferation was indirectly measured by crystal violet staining. Brieﬂy, 5  104 cells were plated in a 96-wells microplate. After 24 h, cells were washed and stained with
crystal violet. The absorbance of the dye was determined at 570 nm. (D) The ability of cells to adhere to laminin, vitronectin, matrigel and ﬁbronectin coatings was analyzed
by plating 104 cells and staining the adhered cells with methylene blue 2 h later. Absorbance of the extracted dye was measured at 655 nm. Results shown in B–D are the
mean ± SD of 3 independent experiments. ⁄p < 0.05. (For interpretation of the references to color in this ﬁgure legend, the reader is referred to the web version of this article.)
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shown) and crystal violet (Fig. 1C) assays, we observed a lower
density of TM1G3 cells 24 h after plating compared with
TM1MNG3 cells. These results are similar to previous ﬁndings that
showed that TM1G3 cells proliferated at a lower rate than
TM1MNG3 cells (Chammas R, personal communication). Finally,
we also noticed that TM1G3 cells have a decreased ability to ad-
here to laminin, ﬁbronectin, vitronectin and matrigel (Fig. 1D).
Overall, these data show that de novo expression of galectin-3 in
anoikis-resistant melanoma cells is associated with an increased
level of melanin, a decreased proliferation rate and a decreased
ability to adhere to several extracellular matrix (ECM) proteins.
All these data were validated with multiple clones.
3.2. TM1G3 cells have an increased susceptibility to oxidant-induced
cell death
To determine the role of galectin-3 in the response to an oxida-
tive stimulus in melanoma cells, we employed the metal complex
[Cu(isaepy)], which has already been shown to induce apoptosis
[24] by the intrinsic pathway in neuroblastoma cells [27]. Exposure
of TM1MNG3 and TM1G3 cells to [Cu(isaepy)] for 24 h led to a
dose-dependent cytotoxicity, as determined by MTT (Fig. 2A) and
crystal violet (data not shown) assays. Treatment with the redox-
inactive [Zn(isaepy)] complex or vehicle alone showed no cytotoxic
effects under the same conditions (Fig. 2A). Interestingly, TM1G3
cells exhibited an increased susceptibility to cell death (viability
was typically 10% lower) when compared with the TM1MNG3 cells
(Fig. 2A). This behavior was also observed when cells were treated
with menadione, a ROS-generating drug, indicating that TM1G3cells are more sensitive to oxidant species (Fig. 2B). Treatment with
60 lM [Cu(isaepy)] showed that loss of cell viability was time-
dependent. No death was detected before 24 h, but after 48 h,
the majority of the cells (80% and 90% for TM1MNG3 and
TM1G3, respectively) had lost viability, which suggests that they
were undergoing cell death (Fig. S2). These data are in agreement
with the slow uptake of [Cu(isaepy)] observed in neuroblastoma
cells, which can take 6–12 h to occur [27]. It is generally accepted
that intracellular galectin-3 has an anti-apoptotic role [44–47],
through its carbohydrate recognition binding domain (CRD), differ-
ently than the extracellular galectin-3, either secreted [48] or exog-
enously added [49], shown to be pro-apoptotic. The presence of
extracellular galectin-3 in the cell culture supernatant was as-
sessed, but we were unable to detect it by immunoblotting, even
after the medium was concentrated (data not shown), which sug-
gests that the observed effects were due to intracellular or mem-
brane-associated galectin-3. Intracellular galectin-3 translocation
was also analyzed by immunoblotting. We observed no altered
expression in any subcellular fraction after exposure to the metal
complexes (data not shown). Thus, intracellular galectin-3 seems
to increase the susceptibility of melanoma cells to cell death fol-
lowing exposure to [Cu(isaepy)]. To investigate if the CRD was in-
volved in the observed cytotoxicity, we performed the same
experiment in the presence of 20 mM lactose. Lactose did not inhi-
bit the cell death process (Fig. S3), indicating that the increased
susceptibility to cell death observed in TM1G3 cells did not involve
the lectin function of galectin-3.
Apoptosis was found to underlie the observed cytotoxicity
(Fig. 2C). Annexin V binding experiments indicated that treatment
with 60 lM [Cu(isaepy)] induced apoptosis after 24 h (80% and
Fig. 2. TM1MNG3 and TM1G3 cell viability after treatment with [Cu(isaepy)] or [Zn(isaepy)]. (A) Cells were treated with the indicated concentrations of [Cu(isaepy)],
[Zn(isaepy)] or the corresponding volume of the vehicle solution (0.1% DMSO) for 24 h. Cell viability was determined by MTT assay. (B) Cells were treated with 60 lM
[Cu(isaepy)], [Zn(isaepy)], vehicle (0.1% DMSO) or 20 lMmenadione for 24 h. Cell viability was determined by MTT assay. (C) Annexin-V-FITC binding to the cell surface was
analyzed by ﬂow cytometry 24 h after treatment with 60 lM [Cu(isaepy)], [Zn(isaepy)] or with the vehicle (0.1% DMSO). (D) Cells were treated with 60 lM [Cu(isaepy)],
[Zn(isaepy)] or with the vehicle for 24 h, after which 104 viable cells were plated on laminin, vitronectin, matrigel and ﬁbronectin coatings. The adhered cells were stained
with methylene blue and quantiﬁed 2 h later. Absorbance of the extracted dye was measured at 655 nm. The results shown are the mean ± SD of 3 independent experiments.
⁄p < 0.05. In A, ⁄p < 0.05 compared with the corresponding vehicle controls or between the TM1MNG3 and TM1G3 cell lines.
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agreement with reports that showed the pro-apoptotic effect of
[Cu(isaepy)] in tumor cells [24,27]. The [Zn(isaepy)] complex was
not active in promoting apoptosis in our model (Fig. 2C).
TM1 (galectin-3 null) parental cells were selected from anoikis-
resistant cells [30]. However, because de novo galectin-3 expres-
sion in such cells decreased their adhesive behavior (Fig. 1D), we
tested whether exposure to [Cu(isaepy)] could lead to an impaired
ability of TM1G3 cells to adhere to ECM proteins. Indeed, TM1G3
cells treated for 24 h with [Cu(isaepy)] and plated on laminin,
ﬁbronectin, vitronectin and matrigel coatings exhibited lower
adhesion than TM1MNG3 cells (Fig. 2D). Although this result could
be interpreted as a consequence of the loss of viability induced by
[Cu(isaepy)], only viable cells were plated in this assay. Together,
these results suggest that [Cu(isaepy)] impaired the adhesion
property of both cell types, and this effect was more pronounced
in the case of TM1G3 cells, which correlates with their increased
susceptibility to apoptosis.3.3. TM1G3 cells are more redox-active than TM1MNG3
To gain insight into the oxidative mechanisms by which de novo
galectin-3 expression increases the susceptibility of a cell to apop-
totic death, we investigated ROS production induced by [Cu(isa-
epy)]. Few reports have investigated the relationship between
endogenous galectin-3 and ROS. While breast cancer cells that ex-
pressed high levels of cell surface galectin-3 produced less ROS
after menadione or TNFa stimuli than those that expressed lower
levels of galectin-3 [47], galectin-3 knockout mice produced less
ROS after ischemia–reperfusion [50] or Toxoplasma gondii infection
[51] compared with wild type mice. Thus, we tested whether the
presence of galectin-3 could alter the amount of intracellular ROS
in melanoma cells. Exposing cells to 60 lM [Cu(isaepy)] for 24 h
led to increases of 70% and 92% in DCFH2-DA intracellular oxida-
tion in TM1MNG3 and TM1G3 cells, respectively, compared with
the vehicle control (Fig. 3A). TM1G3 cells exhibited 35% higher
DCF ﬂuorescence than TM1MNG3 cells, which demonstrates that
Fig. 3. TM1G3 cells are more redox-active than TM1MNG3 cells. Cells were treated with 60 lM [Cu(isaepy)], [Zn(isaepy)] or the corresponding volume of the vehicle (0.1%
DMSO) for 24 h. (A) Intracellular ROS levels were analyzed by ﬂow cytometry after incubating the cells with 10 lM DCFH2-DA. (B) Protein carbonylation was determined by
the DNPH reaction and was examined by photometry. (C) The involvement of superoxide and hydrogen peroxide was analyzed by treating cells with 60 lM [Cu(isaepy)],
[Zn(isaepy)] or with the vehicle (0.1% DMSO) in the presence or absence of either Peg-SOD alone or Peg-CAT plus Peg-SOD for 24 h. Viability was analyzed using the MTT
assay. (D) Annexin-V-FITC binding to the cell surface was analyzed by ﬂow cytometry 24 h after treatment with 60 lM [Cu(isaepy)], or with the vehicle (0.1% DMSO) in the
presence of Peg-CAT plus Peg-SOD. The percentages of non-apoptotic cells are shown. (E) Intracellular GSH levels were quantiﬁed with DTNB, 16 and 24 h after treatment
with 60 lM [Cu(isaepy)] or with the vehicle (0.1% DMSO). The thiol content was normalized to the protein concentrations. (F) GST activity was followed photometrically at
430 nm, using CDNB as substrate, 24 h after treatment with 60 lM [Cu(isaepy)] or with the vehicle. (G) Hydrogen peroxide decomposition activity was monitored at 240 nm,
24 h after treatment with 60 lM [Cu(isaepy)] or with the vehicle. (H) SOD activity was determined by the ability of the extracts to inhibit the nitroblue tetrazolium reduction
by superoxide radicals, 24 h after treatment with 60 lM [Cu(isaepy)] or with the vehicle. The results shown are the mean ± SD of 3 independent experiments. ⁄p < 0.05.
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TM1G3 cells. To determine whether [Cu(isaepy)]-induced ROS
accumulation could promote oxidative damage in melanoma cells
and whether expression of galectin-3 would interfere with the
accumulation of this damage, we measured the protein carbonyl-
ation levels in cells incubated with 60 lM of either metal complexfor 8, 16 and 24 h. The results showed that [Cu(isaepy)] does not
increase protein oxidation at 8 h, but after 16 h the carbonylation
levels were higher in TM1G3 than in TM1MNG3 (Fig. S4). After
24 h of incubation, [Cu(isaepy)] increased protein oxidation by
25% and 48% in the TM1MNG3 and TM1G3 cells, respectively,
compared with the respective vehicle controls (Fig. 3B). The
Fig. 4. [Cu(isaepy)] induces loss of mitochondrial transmembrane potential, but
does not affect the cellular ATP content. Cells were treated with 60 lM [Cu(isaepy)]
or the corresponding volume of the vehicle for 24 h. (A) The membrane potential
was determined by analyzing the ﬂuorescence shift of JC-1 probe by ﬂow
cytometry. Staurosporine (1 lM) was used as a positive control of mitochondria
depolarization. (B) Total cellular ATP content was determined in cells treated with
60 lM [Cu(isaepy)], [Zn(isaepy)] or the corresponding volume of the vehicle for
24 h. Determination was performed with an HPLC system equipped with a UV–VIS
detector set at 260 nm. Values were normalized by the cellular protein concentra-
tions. The results shown are the mean ± SD of 3 independent experiments. ⁄p < 0.05.
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trations at any time analyzed or in any lineage (Fig. 3B), as
expected. Importantly, oxidation was 15% higher in cells express-
ing galectin-3. These data indicate that [Cu(isaepy)] induces
protein oxidation in both cell lines, and expression of galectin-3
is associated with an increased carbonyl stress following treatment
with the compound, as shown by the increased intracellular ROS
levels (Fig. 3A) and the increased cytotoxicity (Fig. 2A–C).
Copper is a redox active biological metal [52], and [Cu(isaepy)]
has been shown to produce ROS [24,26]. To identify the ROS
involved here, we exposed cells to 60 lM [Cu(isaepy)] and the cor-
responding controls, in the absence or presence of polyethylene
glycol-superoxide dismutase (Peg-SOD) for 24 h. Cell-permeable
SOD decreased the observed [Cu(isaepy)] cytotoxicity in both cell
lines, although not completely, as shown by MTT assay (Fig. 3C).
This effect indicates that superoxide toxicity may be associated
with the reduction of Cu(II) to Cu(I), which can produce the very
oxidative hydroxyl radical through the Fenton reaction. We also
investigated the role of hydrogen peroxide because the remaining
cell death could be due to hydrogen peroxide produced by super-
oxide dismutation. Indeed, the presence of either polyethylene gly-
col-catalase (Peg-CAT) (Fig. S5) or simultaneous treatment with
Peg-SOD and Peg-CAT (Fig. 3C) completely abolished the [Cu(isa-
epy)]-induced cytotoxicity observed in both cell lineages. To
conﬁrm that apoptotic death was ROS-dependent, cells were trea-
ted with the metal complexes in the presence of Peg-SOD and Peg-
CAT and the levels of exposed phosphatidylserine were measured.
The results obtained showed that apoptosis was completely inhib-
ited by the simultaneous presence of Peg-SOD and Peg-CAT
(Fig. 3D). Thus, the [Cu(isaepy)]-induced ROS formation, and
possibly the hydroxyl radical produced by the Fenton reaction,
promotes apoptosis in melanoma cells, particularly in galectin-
3-expressing cells, which accumulate higher levels of oxidant
species.
Because galectin-3 has not been shown to be a direct redox
molecule, the mechanisms by which galectin-3-expressing
melanoma cells are more redox-sensitive than TM1MNG3 cells
are unknown. Therefore, we tested whether the presence of galec-
tin-3 alters the antioxidant status of the cells following treatment
with the [Cu(isaepy)] compound. Glutathione (GSH) is usually
consumed after an oxidative insult, and melanoma cells have been
described as very sensitive to GSH depletion [20,21]. Therefore, we
investigated whether intracellular galectin-3 inﬂuenced the inten-
sity of GSH depletion after treatment with the [Cu(isaepy)]
compound. GSH levels were decreased in both cells incubated with
60 lM [Cu(isaepy)] for 16 and 24 h, compared with their respec-
tive vehicle-treated control cells. However, the extent of these
decreases was not signiﬁcantly affected by the expression of galec-
tin-3 (Fig. 3E), suggesting that galectin-3 is not involved in main-
taining intracellular GSH levels. In this scenario of copper
toxicity, GSH might be used directly as an antioxidant or indirectly
as a cofactor of glutathione peroxidase and glutathione-S-transfer-
ase (GST). GST activity has been implicated in determining the
resistance or susceptibility to tumor cell death following exposure
to somemetal complexes, such as cisplatin and arsenic compounds
[19]. The cellular GST activity was determined to be lower in the
TM1G3 than in the TM1MNG3 extracts following treatment with
the vehicle. Treatment with the [Cu(isaepy)] stimulus for 24 h
led to a slight increase (15%) in GST activity in the TM1G3 cells,
most likely as a response to the metal toxicity. However, this in-
crease in activity was not enough to equal the activity measured
in the TM1MNG3 cells (Fig. 3F). Although more a direct evidence
still remains to be found, GST activity may be correlated with the
higher resistance of TM1MNG3 cells to [Cu(isaepy)] toxicity. In
addition, other antioxidant activities were measured. Similarly to
the GST results, the hydrogen peroxide decomposition activitywas higher in the TM1MNG3 than in TM1G3 extracts, under basal
and oxidative conditions, although [Cu(isaepy)] promoted a slight
increase in activity in both cell lines (Fig. 3G). Interestingly, SOD
activity was determined to be higher in galectin-3-expressing cells
than in TM1MNG3 under basal conditions (Fig. 3H), suggesting
that TM1G3 are more adapted than TM1MNG3 to deal with super-
oxide, but not with hydrogen peroxide. But treatment with [Cu
(isaepy)] led to a signiﬁcant increase in SOD activity only in
TM1MNG3, indicating that this cell line is more responsive to
excessive superoxide than TM1G3 cells. Overall, these results
corroborate the idea that galectin-3 expression is associated with
increased susceptibility to ROS due to impaired antioxidant status
and response.3.4. [Cu(isaepy)]-induced mitochondrial membrane depolarization is
more evident in TM1G3 cells
It has been demonstrated that [Cu(isaepy)] has anti-neuroblas-
toma activity by targeting mitochondria [27] and promoting its
dysfunction [28]. Galectin-3 has also been shown to be associated
with mitochondria [53], and our data also indicate that it is present
in this organelle. Thus, to investigate the participation of mito-
chondria in the Cu(isaepy)-induced cytotoxicity, particularly in
galectin-3 expressing cells, we analyzed the mitochondrial trans-
membrane potential with the JC-1 probe. The method was vali-
dated using cells treated with a known inducer of depolarization,
staurosporine (Fig. 4A). The results obtained showed that incuba-
Fig. 5. [Cu(isaepy)] induces a higher level of p38 phosphorylation in TM1G3 cells than in TM1MNG3 cells. Cells were treated with 60 lM [Cu(isaepy)], [Zn(isaepy)] or the
corresponding volume of the vehicle for 24 h. (A) Total protein extract (50 lg/lane) was electrophoresed and immunoblotted with anti-phospho p38 and anti-p38 antibodies.
(B) The bands were quantiﬁed by densitometry, and the ratio of phospho-p38 to total p38 was calculated. (C) p38 activation-dependent cell death was determined by
incubating cells with the metal complexes in the absence or the presence of a 10 lM concentration of the p38 inhibitor SB203580, or with the corresponding inactive
inhibitor (SB202474). Cell viability was determined using the MTT assay. The results shown are the mean ± SD of 3 independent experiments. ⁄p < 0.05.
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brane potential, but TM1G3 cells were more susceptible to the
complex (Fig. 4A), conﬁrming that [Cu(isaepy)] affects mitochon-
drial function, mainly in galectin-3-expressing cells. However, such
loss of the transmembrane potential did not correlate with the
cellular ATP levels in any of the cells (Fig. 4B), suggesting that
oxidative phosphorylation may not be the most important source
of ATP in these cells. Therefore, the JC-1 data indicate that
TM1G3 mitochondria are more susceptible to the mitochondrial
dysfunction induced by [Cu(isaepy)] than TM1MNG3 mitochon-
dria, consistent with the increased susceptibility to apoptosis.3.5. [Cu(isaepy)]-induced p38 phosphorylation is more evident in
TM1G3 cells
It was recently shown that [Cu(isaepy)] induces the activation
of the AMPK/p38/p53 pathway, thereby inducing apoptotic neuro-
blastoma death [29]. Thus, we analyzed whether the MAP kinase
p38 was activated by this compound in our cell lines and whether
the presence of galectin-3 would promote a stronger activation of
p38. TM1G3 cells had a signiﬁcantly higher level of p38 phosphor-
ylation than the TM1MNG3 cells, even under control conditions
(Fig. 5A and B). Treatment of TM1MNG3 and TM1G3 cells with
60 lM [Zn(isaepy)] or [Cu(isaepy)] for 24 h induced p38 phosphor-
ylation (Fig. 5A and B). Similar to the above ﬁndings, the galectin-
3-expressing cells produced a more intense p38 activation after
both metal treatments, though this activation was greater follow-
ing the [Cu(isaepy)] treatment. To determine the role of p38 activa-tion in cell toxicity, we analyzed the cell viability following
exposure to the metal complexes in the absence and presence of
the p38 inhibitors SB239063 (Fig. S6) or SB203580 (Fig. 5C). Expo-
sure to the inactive p38 inhibitor SB202474, as expected, did not
change the cytotoxicity proﬁle observed in the absence of p38
inhibitor (Fig. 5C). The results obtained here clearly demonstrate
that inhibition of p38 resulted in decreased cytotoxicity, thus sup-
porting the hypothesis that [Cu(isaepy)] treatment leads to apop-
tosis by activating p38.4. Discussion
The data presented here show that de novo galectin-3 expres-
sion in an aggressive melanoma cell line increased the apoptosis
susceptibility induced by [Cu(isaepy)] compared with galectin-3-
null cells. This result is particularly interesting for cancer
treatment because galectin-3 expression has been shown to be reg-
ulated during tumor progression [2,3–6,11,54]. Regarding mela-
noma progression, it has been demonstrated that intracellular
galectin-3 expression increases as the tumor progresses from be-
nign nevi to metastatic melanoma [13]. However, more recent data
has shown that its expression level is higher in primary melano-
mas than in dysplastic nevi and metastatic melanoma [11,12].
Our model consisted of a melanoma cell line, TM1, that was de-
rived from anoikis-resistant melan-a cells [30]. TM1 cells, when
transplanted into mice, showed an aggressive and metastatic phe-
notype, thus demonstrating their malignant character and con-
ﬁrming tumor progression [30]. The proteome of TM1 cells is
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the expression of redox proteins [31] and an epigenetic loss of
galectin-3 expression (Chammas R, personal communication).
These data indicate that in our model, progression from melano-
cytes to invasive melanoma is associated with a loss of galectin-3
expression. These data are in agreement with previous clinical data
[11,12], thus making TM1 a good invasive, vertical growth phase
melanoma model derived from progressive tumorigenesis [30].
We then analyzed whether galectin-3 itself can alter the response
of invasive melanoma cells to an oxidative stress stimulus. Our
characterization data suggest that expression of galectin-3 in
TM1 cells appears to rescue some characteristics of the parental
non-tumorigenic, galectin-3-positive melan-a cells [30], such as
melanin production and decreased adhesion to ECM proteins
(Fig. 1B and D). This result could mean that TM1G3 cells are less
aggressive than TM1MNG3 cells. Indeed, the presence of galec-
tin-3 in melanoma has been associated with decreased aggressive-
ness and increased survival [11,12]; however, this question was
not addressed here. More interesting was the ﬁnding that de novo
galectin-3 expression rendered TM1G3 cells more susceptible to
oxidative damage and apoptotic death induced by the copper com-
plex [Cu(isaepy)] [24,27] but not to the redox-inactive [Zn(isaepy)]
complex (Fig. 2).
The proposed mechanisms involved in [Cu(isaepy)]-induced
cell death include the internalization and concentration of the
compound in the mitochondria and nucleus and oxidative damage
to biomolecules [27,28]. [Cu(isaepy)] induces mitochondrial respi-
ratory uncoupling and oxidative damage [28]. In the present work,
although it is clear that ROS formation and accumulation (Fig. 3A,
C, and D), carbonyl stress (Fig. 3B), mitochondrial dysfunction
(Fig. 4A) and p38 activation (Fig. 5) play important roles in cell
death, likely through anoikis (Fig. 2D), the most intriguing question
that remains is how de novo galectin-3 expression potentiates
those effects. Our results indicate that TM1G3 cells have an im-
paired antioxidant system to cope with the excessive ROS produc-
tion induced by [Cu(isaepy)]. This idea is supported by the fact that
GST and the hydrogen peroxide decomposition activities are signif-
icantly lower in the TM1G3 cells compared with the TM1MNG3
cells under basal conditions. And after exposure to the complex,
TM1G3 extracts still present lower GST, SOD and hydrogen perox-
ide decomposition activities than TM1MNG3 (Fig. 3F–H).
Galectin-3 has been shown to play different roles, some even
antagonistic, depending on the cell type, its subcellular localiza-
tion, its post-translational modiﬁcations and various protein inter-
actions. Intracellular galectin-3 has been generally reported to play
pro-proliferative and anti-apoptotic roles [1,55]. However, recent
papers have uncovered novel mechanisms by which galectin-3
can act in anti-proliferative and pro-apoptotic ways, thus support-
ing our data. Galectin-3 was found to induce cell cycle arrest by
stabilizing the cell cycle inhibitor p21 in prostate cancer cells
[56]. Also, in colon carcinoma cells, galectin-3 knockdown was
associated with cell cycle progression and the inhibition of apopto-
sis [53], in agreement with our ﬁndings. Interestingly, in this mod-
el, galectin-3 colocalized with F1F0-ATP synthase in the
mitochondrial inner membrane, inhibiting ATP synthesis [53].
Thus, our results suggest that the TM1G3 cells accumulate more
ROS and are therefore more susceptible to [Cu(isaepy)]-induced
apoptotic death (Figs. 2A and 3D) due to the intrinsic redox activity
of the metal complex in the mitochondria, which is a target of both
the metal complex [27,28] and of galectin-3 function [47,49,53].
However, although [Cu(isaepy)] induced mitochondrial membrane
depolarization, particularly in TM1G3 cells (Fig. 4A), the cellular
ATP content was not affected by mitochondrial dysfunction
(Fig. 4B). We presently cannot explain this data, unless if we con-
sider the Warburg effect, which seems to occur in several mela-
noma cell lines [57]. In this context, it could be supposed thatour cells rely more on glycolytic than on oxidative pathway to syn-
thesize their ATP.
ROS production in other cell compartments also activates p38,
which is a common path to apoptosis [29] and anoikis [58].
Although galectin-3 has a cysteine residue that has been shown
to be involved in the cell adhesion process [59], its exact redox role
is not clearly understood, especially given the pleiotropic roles and
interactions of this protein. Thus, other still unknown indirect
cytotoxic effects of galectin-3 are not excluded. However, indepen-
dent of the speciﬁc molecular interactions underlying the cytotoxic
mechanisms observed here, our data support the assertion that the
[Cu(isaepy)] compound may be envisaged as a prototypic thera-
peutic agent, particularly against galectin-3-positive melanoma
cells.
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